MedPath

MARKSANS PHARMA INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$1.2B
Website

Marksans Pharma Subsidiary Receives UK Marketing Authorization for Metformin Oral Solution

Marksans Pharma's subsidiary Relonchem Ltd received UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) marketing authorization for Metformin Hydrochloride oral solution in 500 mg/5 ml strength.

© Copyright 2025. All Rights Reserved by MedPath